Lab
Esoterix Genetic Laboratories, LLC
Esoterix Genetic Laboratories, LLC was paid $3.21M by Medicaid between Jan 2019 and Dec 2024, across 35 billing codes. Its largest line is 88185, — 35% of everything it billed.
33Billing provider infoESOTERIX GENETIC LABORATORIES, LLC
SHELTON, CT 06484
SHELTON, CT 06484
33aNPI1124536107assigned 01/12/2018
33bProvider typeClinical Medical Laboratory
28Total paid$3.21M
24GClaims61,682
24DCodes billed35
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Connecticut
Rank by total paid#9 of 27
Median peer was paid$561K
This provider vs. median5.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 3,416 | $195K | |
| 2020 | 9,004 | $490K | |
| 2021 | 16,729 | $879K | |
| 2022 | 11,740 | $614K | |
| 2023 | 11,672 | $588K | |
| 2024incomplete | 9,121 | $447K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88185 | 35% | 6,218 | 5,758 | $1.13M | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 11% | 1,147 | 1,144 | $363K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 9.5% | 5,033 | 4,809 | $305K |
| 88341 | 7.8% | 4,060 | 3,262 | $252K | |
| 88189 | 3.7% | 3,891 | 3,679 | $119K | |
| 81329 | 3.5% | 1,437 | 1,433 | $111K | |
| 88184 | 3.3% | 6,211 | 5,765 | $105K | |
| 88342 | 2.8% | 6,280 | 5,378 | $89K | |
| 88360 | 2.6% | 3,246 | 2,744 | $84K | |
| 88275 | 2.6% | 2,199 | 2,068 | $83K | |
| 88237 | 2.4% | 1,778 | 1,658 | $78K | |
| 88271 | 2.1% | 2,389 | 2,245 | $68K |
23 more codes
| 88377 | 1.7% | 699 | $56K | |
| 88264 | 1.5% | 1,205 | $47K | |
| 81206 | 1.2% | 1,150 | $40K | |
| 88323 | 1.2% | 1,249 | $38K | |
| 81207 | 1.1% | 1,160 | $35K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.1% | 1,958 | $34K |
| 82105 | <1% | 2,610 | $27K | |
| 81450 | <1% | 78 | $24K | |
| 88365 | <1% | 566 | $19K | |
| 88313 | <1% | 1,211 | $17K | |
| 81270 | <1% | 803 | $16K | |
| 84702 | <1% | 1,586 | $15K | |
| 88364 | <1% | 243 | $13K | |
| 84163 | <1% | 965 | $9K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 662 | $9K |
| 88182 | <1% | 221 | $7K | |
| 82677 | <1% | 430 | $6K | |
| 81219 | <1% | 248 | $5K | |
| 86336 | <1% | 430 | $4K | |
| 85097 | <1% | 171 | $3K | |
| 81243 | <1% | 26 | $1K | |
| 88311 | <1% | 108 | $573.95 | |
| 88274 | <1% | 14 | $230.02 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILLIAMS, KIMBERLY (VICE PRESIDENT)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.